Table 1 Baseline characteristics of patients
Characteristic | Total (n = 85) | Reduced EF (n = 27) | Preserved EF (n = 58) | P-value |
|---|---|---|---|---|
Age (yr) | 60 (51–66) | 58 (50–66) | 61 (52–65) | 0.467 |
Male sex | 76 (89.4) | 25 (92.6) | 51 (87.9) | 0.712 |
Height (cm) | 168 (163–173) | 168 (163–174) | 168 (163–173) | 0.698 |
Body mass index (kg/m2) | 25.2 (23.5–28.1) | 26.0 (23.5–28.1) | 25.1 (23.5–28.2) | 0.527 |
Body surface area (/m2) | 1.83 (1.72–1.93) | 1.83 (1.78–1.97) | 1.81 (1.70–1.93) | 0.422 |
Hypertension | 32 (37.6) | 10 (37.0) | 22 (37.9) | > 0.999 |
Diabetes mellitus | 29 (34.1) | 10 (37.0) | 19 (32.8) | 0.807 |
Angina | 10 (11.8) | 2 (7.4) | 8 (13.8) | 0.492 |
Prior MI | 5 (5.9) | 1 (3.7) | 4 (6.9) | > 0.999 |
Prior heart failure | 1 (1.2) | 0 (0) | 1 (1.7) | > 0.999 |
Stroke | 5 (5.9) | 1 (3.7) | 4 (6.9) | > 0.999 |
Smoker | 45 (52.9) | 18 (66.7) | 27 (46.6) | 0.105 |
Killip class ≥ 2 | 8 (9.4) | 5 (18.5) | 3 (5.2) | 0.133 |
eGFR | 86.1 (76.7–103.1) | 81.2 (75.6–91.8) | 93.5 (78.7–106.9) | 0.080 |
eGFR < 60 mL/min/1.73 m2 | 8 (9.4) | 1 (3.7) | 7 (12.1) | 0.426 |
ST-elevation MI | 47 (55.3) | 20 (74.1) | 27 (46.6) | 0.021 |
PCI | 85 (100) | 27 (100) | 58 (100) | |
PCI with stents | 84 (98.8) | 27 (100) | 57 (98.3) | > 0.999 |
Culprit lesion | 0.008 | |||
Left main | 2 (2.3) | 1 (3.7) | 1 (1.7) | |
Left anterior descending artery | 43 (50.6) | 20 (74.1) | 23 (39.7) | |
Left circumflex artery | 10 (11.8) | 0 (0) | 10 (17.2) | |
Right coronary artery | 30 (35.3) | 6 (22.2) | 24 (41.4) | |
Medication | ||||
Aspirin | 83 (97.6) | 26 (96.3) | 57 (98.3) | 0.537 |
P2Y12 inhibitor | 85 (100) | 27 (100) | 58 (100) | - |
β-Blocker | 71 (83.5) | 25 (92.6) | 46 (79.3) | 0.208 |
ACEI | 3 (3.5) | 1 (3.7) | 2 (3.4) | > 0.999 |
ARB | 39 (45.9) | 15 (55.6) | 24 (41.4) | 0.250 |
Calcium channel blocker | 10 (11.8) | 3 (11.1) | 7 (12.1) | > 0.999 |
Nitrate | 8 (9.4) | 1 (3.7) | 7 (12.1) | 0.426 |
Statin | 85 (100) | 27 (100) | 58 (100) | - |